| abstract |
PROBLEM TO BE SOLVED: To provide a new therapeutic agent for multiple sclerosis or a medicine for alleviating its pathological condition. SOLUTION: The multiple sclerosis suppressant containing, as an active ingredient, a substance that suppresses the expression of a gene encoding CD11c, CD116, CCL2 or IL-1RA, or a substance that inhibits the function of CD11c, CD116, CCL2 or IL-1RA. Agent. [Selection diagram] None |